Publication | Closed Access

Treatment with risperidone for 4 weeks increased plasma 3-methoxy-4-hydroxypnenylglycol (MHPG) levels, but did not alter plasma brain-derived neurotrophic factor (BDNF) levels in schizophrenic patients

Schizophrenic PatientsPsychiatryPsychotic DisorderPsychopharmacologySchizophreniaNeuropsychiatryNeuropharmacologyNeuroscienceMedicineSocial Sciences